What is Selenium + Myo-Inositol?
Selenium + Myo-Inositol contains 83 mcg of selenium, a critical nutrient in regulating thyroid function, as well as 600 mg myo-inositol, a nutrient that serves key functions relating to hormone signal transduction in the endocrine system. Clinical research indicates that this nutrient combination can help support optimal thyroid function.(2)*
What are the benefits of Selenium + Myo-Inositol?
Selenium + Myo-Inositol is uniquely formulated to support optimal thyroid function, healthy hormone balance, and a healthy immune system. It contains a targeted blend of myo-inositol and selenium (as selenomethionine), which possess synergistic actions in the human body.*
What is the recommended dose?
The recommended dose is one capsule per day.
When should I take it?
This supplement should be taken with a meal.
Can it be taken with thyroid medications?
Selenium + Myo-Inositol should be taken at least 30 to 60 minutes away from thyroid medications. Testing your thyroid hormone levels every 30-90 days to see if a medication adjustment is needed, is recommended.
How long can I take Selenium + Myo-Inositol for?
Selenium + Myo-Inositol can be taken long-term.
Are there any side effects that I should be aware of when taking Selenium + Myo-Inositol?
May cause dizziness, headaches, fatigue, insomnia, and/or agitation.
Consult with a physician before use if pregnant or breastfeeding.
DO NOT TAKE if taking the following medications: antidiabetic drugs, anticoagulant/antiplatelet drugs, barbiturates, blood thinners, and/or immunosuppressants
- Natural Medicines Therapeutic Research Collaboration. https://naturalmedicines.therapeuticresearch.com/. Accessed March 1, 2022.
- Nordio M, Basciani S. Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Patients with Autoimmune Thyroiditis. International Journal of Endocrinology. 2017;2017:2549491. doi:10.1155/2017/2549491.
You May Also Like
Questions about Rootcology Products? Email email@example.com and we will get back to you within 24 business hours.